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Abstract
Concentrations of extracellular divalent cations (Ca
2+ and Mg
2+) fall substantially during intensive synaptic
transmission as well as during some pathophysiological conditions such as epilepsy and brain ischemia. Here we
report that a synthetic serine protease inhibitor, nafamostat mesylate (NM), and several of its analogues, block
recombinant TRPM7 currents expressed in HEK293T cells in inverse relationship to the concentration of extracellular
divalent cations. Lowering extracellular Ca
2+ and Mg
2+ also evokes a divalent-sensitive non-selective cation current
that is mediated by TRPM7 expression in hippocampal neurons. In cultured hippocampal neurons, NM blocked
these TRPM7-mediated currents with an apparent affinity of 27 μM, as well as the paradoxical Ca
2+ influx
associated with lowering extracellular Ca
2+. Unexpectedly, pre-exposure to NM strongly potentiated TRPM7
currents. In the presence of physiological concentrations of extracellular divalent cations, NM activates TRPM7. The
stimulating effects of NM on TRPM7 currents are also inversely related to extracellular Ca
2+ and Mg
2+. DAPI and
HSB but not netropsin, blocked and stimulated TRPM7. In contrast, mono-cationic, the metabolites of NM, p-GBA
and AN, as well as protease inhibitor leupeptin and gabexate failed to substantially modulate TRPM7. NM thus
provides a molecular template for the design of putative modulators of TRPM7.
Background
The eight members of the transient receptor potential
melastatin (TRPM) group represent a subclass of non-
selective cation transient receptor potential (TRP) chan-
nels [1,2]. One of these, the TRPM7 channel, is widely
expressed in various locations throughout the body and,
it is also expressed within the central nervous system.
The function of TRPM7 channels is usually attributed
to one of Mg
2+ homeostasis [3,4] but they are also a
source of entry of Ca
2+ and contribute to the death of
hippocampal neurons following ischemia [5-7]. These
channels are also mechano-sensitive [8], and they con-
tribute to mechanisms controlling vesicular release of
acetylcholine from sympathetic neurons [9].
Although TRPM7 channels are permeable to both Ca
2+
and to Mg
2+, the extracellular presence of these divalent
cations strongly inhibits the influx of monovalent cations,
resulting in strong outward rectification of TRPM7-
mediated currents [3,4]. As a consequence, in the presence
of physiological concentrations of these divalent cations,
inward currents are almost negligible. Oxidative stress
induced by periods of oxygen/glucose deprivation
enhances TRPM7 currents in cultured hippocampal and
cortical neurons and entry of Ca
2+ via these channels can
lead to delayed death of neurons [5,7]. Both the RNA mes-
sage for TRPM7 and the protein itself are expressed in
cultured hippocampal neurons as well as in CA1 pyrami-
dal neurons of the rat [5,7]. Nevertheless, it can be difficult
to detect inward TRPM7-mediated currents in single neu-
rons because their contribution can be small relative to
the large variety of voltage-dependent currents found in
these cells and identification of TRPM7 current is further
impeded by the lack of selective channel blockers [6]. An
alternative approach is to accentuate monovalent cation
influx through TRPM7 channels simply by lowering extra-
cellular concentrations of divalent cations [6,10]. This is
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extracellular concentrations of Mg
2+ and Ca
2+ [11,12] are
characteristic of brain ischemia. In acutely isolated and
in situ CA1 neurons TRPM7 currents can be characterized
using this divalent lowering protocol together with RNAi
techniques. We were able to use this approach to show
that reducing TRPM7 currents in CA1 neurons of the rat
provides substantial protection against the loss of CA1
neurons in a model of global ischemia [5,7].
Protons can compete with Ca
2+ and Mg
2+ for binding
to the channel pore region and thereby relieve the chan-
nel block of monovalent cations [13,14]. Decreasing pH
from 7.4 to 4.0 reduces the IC50 values for monovalent
cation block by 510 and 410 fold for Mg
2+ and Ca
2+,
respectively [15]. The sensitivity of monovalent conduc-
tance to block by Ca
2+ and Mg
2+ in human TRPM7
channels is directly dependent upon the negative charge
provided by two residues, Glu-1052 and Asp-1054, sug-
gesting that divalent cations bind to site incorporating
these two residues [15]. To date, there are few selective
pharmacological tools to study the physiological func-
tions of TRPM7. As TRPM7 currents are blocked by
extracellular Ca
2+ and Mg
2+, we hypothesized that dica-
tionic chemicals could mimic the effects of divalent
cations in blocking TRPM7 channels. Here we report
that the dications NM, DAPI and HSB function as novel
regulators of TRPM7 currents in hippocampal neurons,
likely by competing for divalent cations and thereby
controlling the entry of Ca
2+ and Mg
2+.I nt h ea b s e n c e
of extracellular divalent cations, NM caused a potent
and voltage-dependent inhibition of TRPM7 currents
which mimicked the effects of the divalent cations
themselves. Moreover, the NM-induced inhibition was
occluded as the extracellular concentrations of divalents
were increased suggesting that NM competes with diva-
lent cations for the block of TRPM7 channels.
Methods
TRPM7 Expressed in HEK293T Cells
Electrophysiological recordings were made from
HEK293T cells transfected wild-type (WT) human
TRPM7 or the E1052A, and the D1054A mutant chan-
nels, as previously described [8,13].
Whole-cell and patch recordings were performed on
HEK293T cells at room temperature (22-25°C) with
Axopatch 200B (Molecular Devices, Sunnyvale, CA)
amplifier. For whole-cell recordings, the Cs
+-based
bath solution contained (in mM) 100 Cs-aspartate,
1 EGTA, 10 N-2-Hydroxyethylpiperazine-N’-thanesulfo-
nic acid (HEPES) and 120 mannitol (pH adjusted to 7.4
with CsOH). When required, 1 mM ethyleneglycol-bis-
(a-amino-ethyl ether) N,N’-tetra-acetic acid (EGTA) was
replaced with added CaCl2 and MgCl2 as indictated in
results section. The pipette solution contained 100
C s - a s p a r t a t e ,1E G T A ,1 0H E P E S ,0 . 5C s C l ,a n d1 0 0
mannitol (pH 7.4). The inhibition ratio (%) was calcu-
lated according to the following equation: inhibition
ratio (%) = 100 × [1 - (INM)/(ICtl)], where ICtl is whole-
cell current observed before application of NM at +100
and -100 mV. INM represents the current observed dur-
ing application of NM.
Primary cultures of mouse hippocampal and cortical
neurons
Time-pregnant Swiss mice (embryonic day 16) were
anesthetized with halothane and were decapitated.
Brains of fetuses were removed rapidly and placed in
Ca
2+ and Mg
2+ free ice cold PBS. Whole hippocampus
or cerebral cortices were dissected under a dissection
microscope and incubated with 0.05% trypsin-EDTA for
10 min at 37°C, then triturated with fire-polished glass
pipettes. Cells were counted and plated in poly-L-
ornithine-coated culture dishes at a density of 1 × 10
6
cells per 35 mm diameter dish. Neurons were cultured
with neurobasal medium supplemented with B27 and
maintained at 37°C in a humidified 5% CO2 atmosphere
incubator. Cultures were fed twice a week. Neurons at
14-21 day culture stages were used for electrophysiologi-
cal recordings and calcium image.
Electrophysiological recording on cultured hippocampal
or cortical neurons
Electrophysiological recordings were made from cultured
mouse hippocampal or cortical neurons, 14-20 days after
plating, which were grown as described in [16]. The
extracellular solution (ECF) was composed of (mM) 140
NaCl, 2 CaCl2,1M g C l 2, 25 HEPES, 33 glucose, 5.4 KCl
and 0.0002 tetrodotoxin with pH of 7.3-7.4 and osmolal-
ity ranging from 320-330 mOsm. The intracellular solu-
tion for voltage clamp recording consisted of (mM)
1 4 0C s F ,1 1E G T Aa si n t r a c e l l u l a rC a
2+ chelating buffer,
10 HEPES, 2 MgCl2, 2 tetraethyl ammonium chloride
(TEA-Cl), 1 CaCl2,a n d4K 2ATP. Pipette resistance
ranges were 2-4 MΩ when filled with this intracellular
solution. All recordings were performed at room
temperature. Membrane potential was held at -60 mV
throughout the recording if not otherwise indicated.
Access resistance was monitored by applying a voltage
step of -5 mV. Low divalent cation-induced currents
were elicited by rapid application of low Ca
2+ solution
(0.1 mM Ca
2+ and 0.1 mM Mg
2+ if not otherwise stated)
delivered from a multi-barrelled fast perfusion system for
5 seconds and repeated every minute. The perfusion rate
of the solution was approximately 1 ml per minute.
Whole-cell currents were recorded using an Axopatch-
1D amplifier (Molecular Devices, Sunnyvale, CA). Cell-
attached loose-patch recordings were also preformed as
described previously [6,17]. In those recordings, pipettes
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extracellular solution. Electrophysiological recordings
were filtered at 2 kHz and digitized at 5-10 kHz using a
Digidata 1332A (Molecular Devices, Sunnyvale, CA) or/
and simultaneously through MiniDigi 1A (Molecular
Devices, Sunnyvale, CA), and acquired online with
pClamp8.2 (Molecular Devices, Sunnyvale, CA) or/and
Axoscope9.2 (Molecular Devices, Sunnyvale, CA).
Calcium imaging
Fura-2 fluorescent Ca
2+ imaging was performed as
described previously [18]. Cortical or hippocampal neu-
rons grown on 25 mm round glass coverslips were
washed three times with ECF and incubated with 5 μM
Fura-2-AM for ~ 40 min at room temperature. Neurons
were then washed three times and incubated in normal
ECF for 30 min. Coverslips with Fura-2-loaded neurons
were transferred to a perfusion chamber on the stage of
an inverted microscope (Nikon TE300, Tokyo, Japan).
Cells were illuminated using a xenon lamp (75W) and
observed with a 40 × UV fluor oil-immersion objective
lens. Video images were obtained using a cooled CCD
camera (Sensys KAF 1401, Photometrics, Tucson, AZ)
mounted on an inverted microscope (Nikon TE300,
Tokyo, Japan). Digitized images were acquired, stored,
and analyzed in a PC controlled by Axon Imaging
Workbench software (AIW2.1, Molecular Devices,
Sunnyvale, CA). The shutter and filter wheel (Lambda
10-2, Sutter Instrument, Novato, CA) were also con-
trolled by AIW to allow timed illumination of cells at
340 and 380 nm excitation wavelengths. Fura-2 fluores-
cence was detected at an emission wavelength of
510 nm. Ratio images of 340/380 nm were analyzed by
averaging pixel ratio values in circumscribed regions of
cells in the field of view. The values were exported from
AIW to SigmaPlot (Jandel Scientific, Ekrath, Germany)
for further analysis and plotting.
Data analysis
Data were analyzed with Clampfit 9.2. (Molecular
Devices, Sunnyvale, CA), Excel 2002 (Microsoft Cor-
poration, Redmond, WA), Origin 5.0 (OriginLab Corp.,
Northhampton, MA) and finalized illustrated using Cor-
elDraw X3 (Corel Corporation; Ontario, Canada). Cur-
rents were normalized to the amplitude of control
responses. NM or DAPI inhibitory concentration-
response plots were fitted to the logistic equation: I =
(Amax-A0)/[1+(X/IC50)
n]+A0,w h e r eI is the normalized
current amplitude, X is the antagonist concentration; n
is Hill coefficient; IC50 is the concentration of antagonist
that generate 50% of maximal inhibition. Results are
reported for the text, the figures and amplitude histo-
grams, as mean ± S.E.M. They represent the mean of
n individual measurements on different cells. Statistical
analysis was done with the unpaired or paired t-test,
when appropriate. Chemicals are re-drawn based on the
structures downloaded from Pubchem. NM was pur-
chased from BioMol (Plymouth Meeting, PA) and its
metabolites p-GBA and AN were from TCI and gabex-
ate, DAPI, HSB from Sigma (St. Louis, MO).
Results
NM is a blocker of recombinant TRPM7 currents
expressed in HEK293T cells
Voltage ramps were employed to evoke currents from
over-expressed TRPM7 channels induced in HEK293T
cells. NM failed to inhibit TRPM7 currents in the pre-
s e n c eo f1m MC a
2+ and Mg
2+ (not shown). However,
when extracellular divalents were reduced to 0.1 mM,
N Mi n h i b i t e do u t w a r da n di n w a r dT R P M 7c u r r e n t s
with IC50 values of 617 μM at +100 mV and 514 μMa t
-100 mV (n = 11-14) (Figure 1A). Recordings in diva-
lent-free cation solution further increased the inhibitory
potency of NM by a factor of about 5 fold at +100 mV
and a factor of 30 fold at -100 mV (Figure 1B) (IC50 =
121 μM at +100 mV and IC50 =1 5μM at -100 mV).
Thus, the inhibition by NM depends strongly upon the
concentration of extracellular divalents, and the block-
ade of inward monovalent cation current. The negative
amino acid residues at 1052 and 1054 are important for
the inhibition of monovalent cations in TRPM7 chan-
nels by divalent cations [15]. In this respect, the inhibi-
tion by NM of currents was strongly depressed in
E1052A, but not D1054A expressing HEK293T cells
(Figure 1C &1D), illustrating that that NM inhibition is
dependent upon this site.
NM blocks TRPM7 currents in cultured Hippocampal
Neurons
In recordings from cultured hippocampal neurons,
TRPM7 currents cannot be easily distinguished from a
variety of outwardly rectifying currents [6]. However,
the rectification of inward TRPM7 currents recorded at
hyperpolarized potentials can be dramatically reduced
by lowering the concentration of extracellular divalent
cations; and, this is indicative of the block of inward
cation flux by divalent cations [5,6]. Therefore, we
employed applications of extracellular solutions deficient
in divalent cations to transiently evoke inward TRPM7
currents, with membrane potential clamped at -60 mV.
Extracellular divalents were set at 2 mM Ca
2+ and
1m MM g
2+. We first tested if NM blocks responses of
cultured hippocampal neurons to applications of solu-
tions lacking any added Ca
2+ or Mg
2+. This solution
evoked inward currents that were reversibly blocked by
the co-application of NM (200 μM) (Figure 2A). The
current-voltage (I-V) curve determined before and dur-
ing application of NM demonstrated that the blockade
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Page 3 of 13Figure 1 NM reversibly inhibits TRPM7 currents in HEK293T cells. A i, example peak currents recorded at +100 (filled circle) and -100 mV
(open circle) (Vh = 0 mV) in the presence of 0.1 mM Ca
2+ and 0.1 mM Mg
2+ before and during NM: 100 μM, 250 μM, 500 μM, and 1 mM (filled
bars). ii, example I-V curve for NM-induced inhibition of TRPM7 (+100 mV; IC50: 617 ± 40 μM; Hill coefficient: 1.4; n = 14 and at -100 mV; IC50:
514 ± 39 μM; Hill coefficient: 1.3; n = 14. B. i, example peak currents recorded at +100 (filled circle) or -100 mV (open circle) (Vh = 0 mV) in
divalent free solution before and during NM: 1 μM, 10 μM, 50 μM, 100 μM, and 200 μM (filled bars). ii, example I-V curves of currents before (at
1 in A) and during applications of NM (at 2, 3, 4, 5 and 6 in A). iii, dose-response curve of inhibition by NM at +100 mV; IC50: 121 ± 2 μM; Hill
coefficient: 1.2; n = 6 and at -100 mV; IC50:1 5±2μM; Hill coefficient: 1.3; n = 6. C, example peak currents recorded at +100 (filled circle) and
-100 mV (open circle) (Vh = 0 mV) in the presence of 0.1 mM Ca
2+ and 0.1 mM Mg
2+ before (a, d, g), during (b, e, h) and after (c, f, i) 1 mM NM.
D, example I-V curves for WT TRPM7, E1052A, and D1054A mutants. E, inhibition of the average current density of inward currents mediated by
WT TRPM7 or its mutants, recorded at -100 mV. Each column represents the mean ± s.e.m. (n = 7-14), ***, P < 0.001 vs. WT.
Chen et al. Molecular Brain 2010, 3:38
http://www.molecularbrain.com/content/3/1/38
Page 4 of 13of these currents was strongly voltage-dependent. Since
this zero divalent cation solution has uncertain concen-
trations of Ca
2+ and Mg
2+, we thereafter used a solution
containing added divalent cations (100 μMC a
2+,1 0 0
μMM g
2+). NM similarly blocked inward currents
evoked by this low divalent cation solution. The IC50 for
the block by NM was 27 μM (Figure 2C). Both the
onset and the recovery from the inhibition occurred
rapidly suggesting that NM directly blocks the channels
underlying the current. Although, this result paralleled
what was observed with over expression of TRPM7
channels, it occurred at a much higher concentration of
extracellular divalent cations.
NM inhibits TRPM7-induced increases in intracellular
Ca
2+ in cultured hippocampal and cortical neurons
Reducing extracellular Ca
2+ paradoxically induces Ca
2+
influx into hippocampal neurons via TRPM7 channels
[16,19]. To test if NM inhibits this influx of Ca
2+,w e
used Ca
2+ imaging techniques to monitor Ca
2+ entry. In
cultured hippocampal neurons a decrease of extracellu-
lar Ca
2+ from 2.0 mM to 0.5 mM (absence of added
Mg
2+) induced a net increase of the 340/380 ratio by
2.64 ± 0.48 (n = 11, p < 0.01). Bath perfusion of
NM (50 μM) reduced the 340/380 ratio to 0.61 ± 0.32
(n = 9, p < 0.01, Figure 3A). A similar inhibition was
observed in cultured mouse cortical neurons where bath
perfusion of NM (50 μM) reduced the net increase
of 340/380 ratio nm from 1.17 ± 0.03 to 0.20 ± 0.08
(n = 5, p < 0.05, not shown). However, NM (50 μM) did
not affect the increase of intracellular Ca
2+ induced by
applying KCl (50 mM). The net increase of 340/380
ratio was 1.67 in the absence of NM, and it was 1.84 in
its presence illustrating that NM does not inhibit the
rise in Ca
2+ entry simply by preventing depolarization.
NM attenuates low calcium-induced neuronal excitation
Lowering extracellular Ca
2+ potently increases neuronal
excitation by eliciting an inward current [10,16,17]. We
therefore tested if NM, by blocking TRPM7 currents,
could affect neuron excitation upon reducing Ca
2+.T o
exclude the involvement of changes in seal conductance
due to low extracellular Ca
2+ concentration, we used on-
cell loose patch technique [6] to record on-cell inward
current spikes reflecting action potentials. Since neuronal
excitation can be detected with decrease from physiologi-
cal concentrations of as little as 100 μM [10], we reduced
the Ca
2+ concentration to 0.5 mM. Figure 3B shows
neuron firing was increased upon application of 0.5 Ca
2+
and NM attenuated neuron firing frequency from 8.5 ±
2.7 Hz to 6.8 ± 2.9 Hz (p < 0.05, n = 16) illustrating
that NM dampens the excitation by blocking the low
Ca
2+-induced current.
NM also activates TRPM7 currents?
Next we examined the effect of pre-applying NM on the
response to low divalent cations. Unexpectedly, rather
than inhibiting the currents pre-applied NM (200 μM)
dramatically potentiated evoked currents by about 3.6 ±
0.4 fold (n = 7, p ≤ 0.01) (Figure 4A). This occurred even
though simultaneous applications of NM entirely blocked
responses to lowered divalent cations (Figure 4A). This
finding prompted us to determine whether or not NM
might be capable of activating TRPM7 currents in the
presence of physiological concentrations of divalent
Figure 2 NM completely and reversibly inhibits TRPM7 current
in cultured mouse hippocampal neurons. A, top, experimental
protocol showing voltage ramps (-100 to +100 mV) and applied low
divalent cations. TRPM7 was elicited by lowing divalent cations from
2m MC a
2+,1m MM g
2+ to indicated lower concentrations. Bottom,
current trace examples of 0 Ca
2+ and 0 Mg
2+-induced TRPM7 current
at the presence and absence of NM. Co-application of NM (200 μM)
reversibly blocked TRPM7 evoked by zero divalent cations. n = 6. B,
NM (200 μM) completely blocks TRPM7 evoked by 0.1 mM Ca
2+ (and
0.1 mM Mg
2+). Example current traces superimposed (left) and I-V
curve (right). n = 8. C, concentration response of NM blockade of
TRPM7 current, Left, currents trace examples. NM was acutely applied
in the presence of 0.1 mM Ca
2+ and 0.1 mM Mg
2+. The onset time
constrant of NM inhibition (200 μM) was 0.29 ± 0.04 s (n = 9) and the
offset time constant was 1.07 ± 0.20 s (n = 9). Exponential fitting
curves (red) were inserted with the trace (when NM is 200 μM). Right,
concentration response curve of NM inhibition; IC50:2 7±6μM; hill
coefficient: 1.4; n = 6.
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the presence of 2 mM Ca
2+ and 1 mM Mg
2+, induced
small inward currents (Figure 4B). Voltage ramps
demonstrated that this NM-induced current reversed at
0 mV. However, a concentration of NM close to IC50 for
the block of TRPM7 currents was without effect
(Figure 4B).
To verify that the both types of responses reflect acti-
vation of the same population of cation channels we
designed a protocol to first activate the currents using a
Figure 3 NM attenuates low-divalent-cation-induced Ca
2+ influx and action potentials in cultured hippocampal neurons.A ,c a l c i u m
image; representative changes in ratio images (top) and 340/380 nm ratio values (bottom) by lowering Ca
2+ from 2 mM to 0.5 mM and Mg
2+
from 1 mM to 0 mM. NM (50 μM) was co-applied with low divalent cations. B, summarized data shows the reduction of low divalent-cation-
induced increase of 340/380 nm ratio by NM, **p < 0.01. n = 11. B. NM (200 μM) reduced the frequency of action potentials in on-cell loose
patch induced by lowering divalent cations. Action potentials were induced by 0.5 mM Ca
2+ and 0.5 mM Mg
2+. Left, trace examples; right,
statistic analysis. Black circle shows the mean of firing frequency. Firing frequency was significantly (p < 0.05) reduced from 8.5 ± 2.7 Hz (control)
to 6.8 ± 2.9 Hz (adding NM) and back to 8.0 ± 2.4 Hz after washing out NM, n = 16.
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presence of control concentrations of divalent cations.
This was followed by short period of washout of NM.
Figure 4C shows that a brief NM-washout lead to an
enhancement of TRPM7 currents that was subsequently
suppressed when NM was re-introduced (n = 5), indi-
cating the NM-activated current is blocked by NM. This
suggests that NM both blocks TRPM7 currents and
paradoxically activates it in the presence of physiological
concentrations of divalent cations. If NM-activated cur-
rents and TRPM7 currents share the same identity, then
Ca
2+ per se should affect NM-activated currents.
Therefore, we tested if high Ca
2+ blocks the NM-
activated current. Indeed, addition of 10 mM Ca
2+
inhibited NM-activated currents and moreover the
presence of 10 mM occluded the activation of NM-
activated current (Figure 5A). The amplitude of the
Figure 4 NM potentiates and also activates TRPM7 channels in
hippocampal neurons. A, left, trace examples of the TRPM7
currents. TRPM7 was evoked by 0.1 mM Ca
2+ (and 0.1 mM Mg
2+). Pre-
expose: NM (200 μM) was applied before lowering divalent cations for
1-2 minutes; co-apply: NM (200 μM) was applied together with 0.1 mM
Ca
2+ (and 0.1 mM Mg
2+). Right, bar graph showing the potentiated
ratio by NM on the TRPM7. n = 7, ***, p < 0.01 vs. control. B, NM opens
TRPM7 at the physiological concentration of divalent cations. Left,
examples of TRPM7 current trace monitored by voltage ramps
(-100 mV to 100 mV). Divalent cation concentration was 2 mM Ca
2+
and 1 mM Mg
2+. Right, I-V curve from voltage ramps. 200 μMN M
caused marked while 25 μM NM have little effects on TRPM7, n = 6. C,
NM activates and also blocks TRPM7 channel. Left, trace example of
NM-induced current. Bath solution contained 2 mM Ca
2+ and 1 mM
Mg
2+ and stayed unchanged. Black bar indicates application of NM
and white bar indicates washout of NM. NM (200 μM) at the
physiological concentration of cations directly induces an inward
current, which became larger upon brief NM removal (inset enlarged).
n = 5. Right, bar graph showing amplitude of NM-induced current
(243 ± 66 pA) compared to current amplitude upon NM washout
(379 ± 86 pA). Figure 5 NM-activated TRPM7 in hippocampal neurons depends
on extracellular Ca
2+ concentration.A ,r i g h t ,1 0m MC a
2+ blocks NM
(200 μM)-induced TRPM7 current, n = 7. Left, high Ca
2+ (10 mM) but
not 2 mM Ca
2+ occlude the TRPM7 activation by NM (200 μM ) ,n=6 .B ,
left, NM elicited almost no current at 10 mM Ca
2+ (with 1 mM Mg
2+),
small TRPM7 current at 2 mM Ca
2+ (with 1 mM Mg
2+) and large TRPM7
current at 0.1 Ca
2+ (with 0.1 Mg
2+) (n = 8). Right, bar graph shows
statistics of NM-induced current at various Ca
2+ conditions. The current
amplitudes were 147 ± 20 pA at 10 mM Ca
2+; 291 ± 52 pA at 2 mM
Ca
2+ and 1018 ± 120 pA at 0.1 mM Ca
2+. C, TRPM7 current activated by
NM was inhibited 97 ± 2% by Gd
3+ (10 μM), n = 5. Left, current-trace
example; right, bar graph showing statistics of current amplitude. D,
NM-induced Ca
2+ entry in hippocampal neurons is attenuated by high
extracellular Ca
2+. NM (200 μM)-induced Ca
2+ entry monitored by Ca
2+
imaging and high extracellular Ca
2+ (5 mM) attenuated the Ca
2+ entry.
**, p < 0.01, 2 mM versus 5 mM Ca
2+, n = 22. Bath solution contain no
Mg
2+ and MK801 (10 μM), CNQX (20 μM) and nimodipine (5 μM) was
supplemented.
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concentration of extracellular Ca
2+:a t1 0m MC a
2+ NM
induced little current; at 2 mM Ca
2+ NM slowly induced
a relatively small current; and at 0.1 Ca
2+ mM NM
rapidly evoked a large current that could be readily
blocked upon re-application 10 mM Ca
2+ (Figure 5B,
n = 6). NM-induced currents were also inhibited by
10 μMG d
+3 (Figure 5C, n = 5) consistent with its iden-
tification as TRPM7 currents [6]. These data indicate
that NM activates the same currents as the response to
low divalent cations solutions.
NM also induces paradoxical entry of Ca
2+
We used Ca
2+ imaging to test if NM-activated currents
lead to Ca
2+ influx as do those activated by applications
of low concentrations of Ca
2+.F i g u r e5 Ds h o w sa ti n
the presence of 2 mM Ca
2+, NM induced an increase in
the intracellular concentration of Ca
2+. However,
increasing extracellular Ca
2+ to 5 mM substantially (p <
0.01) attenuated the NM-induced Ca
2+ increase as it
also depressed NM-induced inward currents.
NM and divalent cation block of recombinant TRPM7
channels in HEK293T cells
We next returned to recordings of recombinant TRPM7
channels in HEK293T cells to determine if NM similarly
interacted with the divalent cation block of these cur-
rents (Figure 6). The effect of NM on the block of
TRPM7 currents was examined on the inhibition of
these currents by extracellular divalent cations (10 nM
versus 0.1 mM) (Figure 6A &6B). The presence of
500 μM NM substantially reduced the blocking potency
of this divalent cation (Figure 6B) and is consistent with
our observations in cultured hippocampal neurons.
Furthermore, an enhancement of TRPM7 currents by
NM was also observed (Figure 6C, D &6E).
NM analogues block TRPM7 currents in cultured
hippocampal neurons
NM is a linear di-cation characterized by an amidine
group at one terminus and a guanidine group at the other
[20] (Figure 7A). NM is an ester conjugate that can be
rapidly hydrolyzed in vivo into AN and p-GBA by
esterases in the liver and blood. We next tested whether
these metabolites mimic NM’se f f e c to nT R P M 7 .p - G B A
(up to 1 mM) neither inhibited (through co-application)
nor potentiated (pre-exposed application) TRPM7 current
(Figure 7B). Co-applied AN (1 mM) only partially inhib-
ited TRPM7 and pre-applied AN produced no potentia-
tion (n = 5, Figure 7C). These results suggest that the both
sides of NM are required for the modulation. As NM is a
protease inhibitor, we next asked if other linear proteases
inhibitors, which share some structural similarity with
NM, might modulate TRPM7. We tested protease
inhibitors leupeptin and gabexate (Figure 7A) (only having
a positive-charged guanidine group at one terminus).
Leupeptin (200 μM) had no inhibitory or potentiating
effects (not shown). Gabexate (200 μM) only partially
inhibited (45 ± 3%, n = 6) TRPM7 current and failed to
potentiate the currents (not shown). These results imply
that to reach full potency of modulation the di-cationic
module of NM appears to be essential. To further examine
if the di-cationic structure is sufficient for the modulation
we assessed netropsin (Figure 7A), a basic polypeptide
isolated from Streptomyces netropsis. Netropsin is also a
di-cation which, like NM, possesses an amidine group at
one end and a guanidine group at the other. We found
netropsin (200 μM) neither blocked the current when
co-applied, nor potentiated it when pre-exposed (not
shown), indicating not all di-cationic molecules affect
TRPM7 current and specific structure of di-cations is
required. We also found that synthalin (200 μM), a com-
plete linear double-charged bi-guanidine, did not block or
potentiate TRPM7 (not shown). Thus, double-charged ter-
mini are not sufficient for modulating the TRPM7 and
confirm the typical inner motif of NM is important.
To verify this we tested several compounds with ben-
zene rings on their outer edge such as DAPI and HSB.
Both DAPI and HSB are di-cations but with amidine
groups at both termini. DAPI completely and reversibly
blocked TRPM7 current with an IC50 of 38 μMb u ta l s o
directly activated the current in the presence of physiolo-
gical concentrations of divalent cations (Figure 8A & 8B).
Co-applications of HSB (200 μM) inhibits TRPM7 cur-
rent and pre-exposed HSB (200 μM) strongly potentiates
(by 6.0 ± 1.0 fold, n = 6) it (Figure 8C). HSB also directly
activated the currents in the presence of physiological
concentrations of divalent cations (not shown). The
effects of DAPI and HSB on TRPM7 were similar to
those of NM indicating that more than a di-cationic
structure is required for this modulation. We also exam-
ined the actions of NM on CA1 neurons in the hippo-
campal slice in order to confirm whether or not NM was
capable of inhibiting and activating this current in CA1
neurons in situ. The diffusion barriers presented in the
slice preparation preclude very rapid changes in divalent
cation concentrations but prolonged solution changes
can be used to activate TRPM7 currents in this prepara-
tion [19]. Lowering concentrations of divalent cations
induced a slowly activating inward current that was atte-
nuated by the co-perfusion of NM (not shown).
Discussion
Reductions in the concentration of divalent cations dra-
matically enhance inward currents mediated by recom-
binant TRPM7 channels, expressed in cell lines as well
as in hippocampal neurons [6,21,22]. This enhancement
is highly dependent upon membrane potential and
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Page 8 of 13Figure 6 Effects of NM on the divalent cation sensitivity of TRPM7 currents. (A) representative I-V relationships for currents in response to
voltage ramps (50 ms duration) from +100 mV to -100 mV (Vh = 0 mV) recorded with extracellular divalents at 10 nM and 0.1 mM in the
absence (left) and presence of 500 μM NM (right). B, dose response curve for the inhibitory effect of divalents on TRPM7 current. Concentration
response curve of NM inhibition at +100 mV in the absence of NM; IC50: 2.3 ± 0.2 μM; hill coefficient: 0.8; n = 9 and in the presence of NM; IC50:
200 ± 40 μM; hill coefficient: 0.8; n = 8. C, NM potentiates TRPM7 channels in TRPM7-transfected HEK293T cells under ramp-clamp (every 5 s at
4 mV/ms). Representative peak inward currents recorded at -100 mV (circle) (Vh = -60 mV) in the presence of 1 mM Ca
2+ and 1 mM Mg
2+.D ,
representative I-V relationships of currents evoked by 0.1 mM Ca
2+ and 0.1 mM Mg
2+ in response to voltage ramps before (a), during (b), and
after (c) NM application. E, bar graph showing the potentiated ratio by NM on the TRPM7. n = 11, ***, p < 0.01 vs. control.
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Page 9 of 13reflects, at least in part, the inhibition of TRPM7 mono-
valent cation flux by extracellular divalent cations.
Therefore, current flow through these channels is not




NM is a commonly used anti-inflammation and anti-
coagulation compound [20,23-25]. Accumulating evi-
dence suggests that besides conventional clinical usage
NM also shows a myriad of other beneficial effects such
as liver protection [26,27], ion channel blockade [28],
and pain relief [29]. Our study shows that NM, as well
as DAPI and HSB, reversibly block TRPM7 currents in
HEK293T cells and TRPM7 currents in cultured hippo-
campal neurons, provided extracellular divalent cation
concentrations are low. In contrast, the NM metabolites,
p-GBA and AN were without effect.
Figure 7 p-GBA and AN have no or weak effects on TRPM7
current in hippocampal neurons. A, chemical formulas of NM,
p-GBA/AN, DAPI, HSB, gabexate, netropsin, synthalin. B, left, bar-
graph of normalized current showing co-applied p-GBA (1 mM)
did not block TRPM7 current. I p-GBA /I control was 94 ± 3%, p =
0.23, n = 4. Right, bar-graph; pre-exposed p-GBA (1 mM) did not
potentiate TRPM7 current. I p-GBA /I control w a s9 6±1 % ,p=0 . 8 6 ,
n = 3. C, left, co-applied AN (1 mM) slightly blocked TRPM7
current. I AN /I control was 69 ± 29%, p = 0.03, n = 6. Right, pre-
applied AN (200 μM) did not potentiate TRPM7 current. I AN /I
control w a s8 5±5 % ,p=0 . 6 ,n=5 .
Figure 8 DAPI and HSB strongly modulate TRPM7 current in
hippocampal neurons. A, i, DAPI (250 μM) completely and
reversibly blocked TRPM7 current (evoked by 0.1 mM Ca
2+ and
0.1 mM Mg
2+) in cultured hippocampal neuron, n = 5. ii, left,
representative current traces of TRPM7 current blocked with various
concentrations of DAPI. DAPI was acutely applied and washed out
as indicated by black bar. DAPI rapidly blocked TRPM7 current. iii,
concentration response of DAPI blockade of TRPM7 current. IC50:
38 ± 8 μM; hill coefficient: 1.8; n = 5. B, DAPI activated TRPM7 at
2m MC a
2+ and 1 mM Mg
2+, voltage ramps (-100 mV to 100 mV).
Right, I-V plot. 100 μM DAPI have strong effect while 25 μM was
without effect, n = 5. C, and D, HSB has similar effect as NM on
TRPM7. C, co-applied HSB (200 μM) blocks TRPM7 current. D, pre-
exposed HSB (200 μM) potentiated TRPM7 current by 6.0 ± 1.0 fold,
n = 6, p < 0.01; while co-applied HSB inhibited 90 ± 1% of TRPM7
current, n = 5.
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expressed in HEK293T cells in direct inverse relation-
ship to the extracellular concentrations of Ca
2+ and
Mg
2+. In the absence of extracellular divalent cations,
NM caused a potent and voltage-dependent inhibition
of TRPM7 currents which mimicked the effects of the
divalent cations themselves. The NM-induced inhibition
was occluded as the extracellular concentrations of diva-
lents were increased suggesting that NM competes with
divalent cations for the block of TRPM7 channels.
In cultured hippocampal neurons we demonstrated
that NM, and related compounds, cause a strong mem-
brane potential-dependent inhibition of TRPM7 currents
as well as an inhibition the excitatory responses evoked
by lowering extracellular concentrations of divalent
cations. In previous publications we showed that these
currents are at least mediated in large part, if not
entirely by TRPM7 channels, as they are negatively cor-
related with a selective knockdown of TRPM7 protein
and messager both in cultured hippocampal and in vivo
CA1 pyramidal neurons [5-7]. TRPM7 and TRPM7-like
currents are both partially inhibited by 2-APB and neo-





[6,10,30]. The potency of the block in HEK293T cells
and cultured neurons is similar and also supports the
substantial involvement of endogenous TRPM7 channels
in the responses of neurons to low concentrations of
divalent cations [6]. TRPM7 proteins have also been
reported to form functional heteromeric channels with
TRPM6 and these channels demonstrate somewhat dif-
ferent characteristics than homomeric TRPM7 channels
[ 3 1 ] .H o w e v e r ,w ec a n n o tr u l eo u tt h ep o s s i b i l i t yt h a t
other types of channels (e.g. hemi-gap channels), that
are also sensitive to extracellular divalent cations, may
also contribute in part to the response of hippocampal
pyramidal neurons to brief applications of divalent free
solutions [21,22].
Pre-applications of NM prior to reducing extracellular
divalents lead to an unanticipated enhancement of the
TRPM7 currents. Furthermore, applications of relatively
high concentrations of NM were able to directly evoke
TRPM7 currents in the presence of intermediate concen-
trations of divalent cations. Both of these effects were
dependent upon membrane potential as well as the extra-
cellular concentrations of divalents. These results
demonstrate that NM, and divalent cations likely com-
pete for regulation of TRPM7 currents. Comparing the
s t r u c t u r eo fN M ,H S Ba n dD A P I ,w en o t es o m es t r u c -
tural commonalities, for example they are linear dications
characterized either by amidino or guanidino groups
at both termini together with a variable bulk group
(benzene rings) on the outer edge of the molecule. Their
ability to mimic the actions of Ca
2+ and Mg
2+ in the
modulation of TRPM7 suggests that they can bind to the
same sites on the underlying channel proteins. A parsi-
monious and consistent interpretation is that NM
competes with the binding of divalent cations. At hyper-
polarized membrane potentials NM can block these
channels when divalent cation concentrations are low
but it can also displace divalent binding with the concen-
trations are higher. This interpretation is consistent with
observations that protons also compete with divalent
cations in TRPM7 channels to dramatically enhance cur-
rents [14]. It is also consistent with our previous observa-
tions that protons can inhibit TRPM7 currents in the
absence of divalent free cations [17]. At pH 7.4 both the
glutamate at 1052 and the aspartate at 1054 are impor-
tant for the inhibition of divalent cations [15]. NM may
be able to access 1052 whereas the deeper 1054 site
located in narrowing of the pore is inaccessible [32].
Netropsin, like NM, contains a guanidine group at one
end and an amidine group at the other but has a longer
structure and is less symmetric than NM. Netropsin had
no effect on TRPM7 currents suggesting the length, the
relative overall symmetry or the position of bulky group
might be important for TRPM7 modulation. The data
with synthalin is also consistent with this argument.
Both leupeptin and gabexate are protease inhibitors and
do not strongly affect TRPM7 showing that protease
inhibitors having a guanidine group do not necessarily
modulate TRPM7 currents; although, NM and gabexate
inhibit a similar spectrum of serine proteases [33].
The capacity of NM, HSB and DAPI to block TRPM7
current suggests a molecular structure which might be
explored for the development of agents that block the
contributions of these currents to the pathophysiological
over activation of central neurons in epilepsy and/or
ischemia. Substantial, but transient decreases in extra-
cellular divalent cations are commonly observed in the
CNS during pathological events such as epileptic sei-
zures and ischemic conditions [34], and low Ca
2+
enhances membrane excitability [10,16]. Compounds
based on NM might be anticipated to have little effect
until there was a large and pathological decrease in the
extracellular concentrations of divalent cations. In this
situation they might be anticipated to block TRPM7
currents and therefore reduce the deleterious effects of
an influx of Ca
2+ and provide a unique mechanism that
targets the inappropriate activation of TRPM7 channels.
However, the ability of NM to compete with divalents
for TRPM7 currents would also potentially predispose
activation of TRPM7 currents resulting in enhancement
of the currents. In other words they would greatly
exacerbate the effects of lowered divalent cations during
pathological conditions; and, they would potentially
prove excitotoxic rather than neuroprotective. However,
in their role as potential activators of TRPM7 they
could be used to probe physiological functions these
Chen et al. Molecular Brain 2010, 3:38
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Page 11 of 13channels in hippocampal neurons as well as their possi-
ble role during synaptic transmission at synapses where
Ca
2+ are likely to fall to very low concentrations [35,36].
Thus, our results provide information about a molecular
motif (template) that could be employed to design
antagonists or agonists of TRPM7.
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